1. Home
  2. IT vs GH Comparison

IT vs GH Comparison

Compare IT & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gartner Inc.

IT

Gartner Inc.

HOLD

Current Price

$156.60

Market Cap

16.8B

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$100.76

Market Cap

14.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IT
GH
Founded
1979
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.8B
14.8B
IPO Year
1993
2018

Fundamental Metrics

Financial Performance
Metric
IT
GH
Price
$156.60
$100.76
Analyst Decision
Hold
Strong Buy
Analyst Count
10
21
Target Price
$270.44
$102.81
AVG Volume (30 Days)
1.7M
2.1M
Earning Date
02-03-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
11.49
N/A
Revenue
$6,459,775,000.00
$902,569,000.00
Revenue This Year
$6.73
$35.23
Revenue Next Year
$3.29
$27.38
P/E Ratio
$13.60
N/A
Revenue Growth
5.24
30.38
52 Week Low
$139.18
$34.88
52 Week High
$544.93
$120.74

Technical Indicators

Market Signals
Indicator
IT
GH
Relative Strength Index (RSI) 17.05 38.60
Support Level $139.18 $97.88
Resistance Level $239.25 $118.00
Average True Range (ATR) 9.53 5.67
MACD -8.78 -1.94
Stochastic Oscillator 13.29 11.61

Price Performance

Historical Comparison
IT
GH

About IT Gartner Inc.

Gartner Inc provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services. The company operates through three business segments, namely Research, Conferences and Consulting. The company generates majority of the revenue from Research segment.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: